Pharmacometrics: A Multidisciplinary Field to Facilitate Critical Thinking in Drug Development and Translational Research Settings
- 1 May 2008
- journal article
- review article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 48 (5), 632-649
- https://doi.org/10.1177/0091270008315318
Abstract
Pharmacometrics has evolved beyond quantitative analysis methods used to facilitate decision making in drug development, although the application of the discipline in this arena continues to represent the primary emphasis of scientists calling themselves pharmacometricians. While related fields populate and interface with pharmacometrics, there is a natural synergy with clinical pharmacology due to common areas of research and the decision-making expectation with respect to evolving conventional and translational research paradigms. Innovative and adaptable training programs and resources are essential in this regard as both disciplines promise to be key elements of the clinical research workplace of the future. The demand for scientists with pharmacometrics skills has risen substantially. Likewise, the salary garnered by those with these skills appears to be surpassing their counterparts without such backgrounds. Given the paucity of existing training programs, available training materials, and academic champions, a virtual faculty and online curriculum would allow students to matriculate into one of several programs associated with their advisor but take instruction from faculty at multiple institutions, including instructors in both industrial and regulatory settings. Flexibility in both the curriculum and the governance of the degree would provide the greatest hope of addressing the short supply of trained pharmacometricians.Keywords
This publication has 39 references indexed in Scilit:
- eDrug: a dynamic interactive electronic drug formulary for medical studentsBritish Journal of Clinical Pharmacology, 2006
- The Crisis of Resistance: Identifying Drug Exposures to Suppress Amplification of Resistant Mutant SubpopulationsClinical Infectious Diseases, 2006
- Directors of Pharmacology Graduate Programs: Pharm PhorumMolecular Interventions, 2006
- Impact of pharmacometrics on drug approval and labeling decisions: A survey of 42 new drug applicationsThe AAPS Journal, 2005
- Challenges in the transition to model-based developmentThe AAPS Journal, 2005
- Comparison of rheumatoid arthritis clinical trial outcome measures: A simulation studyArthritis & Rheumatism, 2003
- The NIH RoadmapScience, 2003
- Utilisation of Pharmacokinetic- Pharmacodynamic Modelling and Simulation in Regulatory Decision-MakingClinical Pharmacokinetics, 2001
- Economic Evaluations During Early (Phase II) Drug DevelopmentPharmacoEconomics, 2001
- Biological simulations in drug discoveryDrug Discovery Today, 1999